Nonsteroidal anti-inflammatory drugs decrease the risk of PD [116], and inflammatory cytokines are increased in the serum and/or cerebrospinal fluid of PD patients [IL-2, TNFα, IL-6, RANTES, osteopontin, and IL-1β]. Here, CCL5 is linked to Parkinson disease.